Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure.
<h4>Background</h4>Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and is a serious public health problem throughout Latin America. With 6 million people infected, there is a major international effort to develop new drugs. In the chronic phase of the disease, the pa...
Saved in:
Main Authors: | Amanda Fortes Francisco (Author), Ursula Saade (Author), Shiromani Jayawardhana (Author), Hans Pottel (Author), Ivan Scandale (Author), Eric Chatelain (Author), Peter Liehl (Author), John M Kelly (Author), Maan Zrein (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of a Novel Multiplex Immunoassay Multi-cruzi for the Serological Confirmation of Chagas Disease.
by: Elodie Granjon, et al.
Published: (2016) -
A novel high performing multiplex immunoassay Multi-HTLV for serological confirmation and typing of HTLV infections
by: Lola Marqué, et al.
Published: (2021) -
A novel high performing multiplex immunoassay Multi-HTLV for serological confirmation and typing of HTLV infections.
by: Lola Marqué, et al.
Published: (2021) -
Expanding the toolbox for Trypanosoma cruzi: A parasite line incorporating a bioluminescence-fluorescence dual reporter and streamlined CRISPR/Cas9 functionality for rapid in vivo localisation and phenotyping.
by: Fernanda Cristina Costa, et al.
Published: (2018) -
Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection.
by: Gurdip Singh Mann, et al.
Published: (2020)